Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US7022340 | FERRING | Pharmaceutical composition as solid dosage form and method for manufacturing thereof |
Apr, 2023
(a year ago) |
Desmopressin Acetate is owned by Ferring.
Desmopressin Acetate contains Desmopressin Acetate.
Desmopressin Acetate has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Desmopressin Acetate are:
Desmopressin Acetate was authorised for market use on 08 May, 2008.
Desmopressin Acetate is available in tablet;oral dosage forms.
The generics of Desmopressin Acetate are possible to be released after 30 April, 2023.
Drugs and Companies using DESMOPRESSIN ACETATE ingredient
Market Authorisation Date: 08 May, 2008
Treatment: NA
Dosage: TABLET;ORAL